Social Anxiety Disorder Affects 15 Million U.S. Adults and is More Common Among Women than Men
FDA Converts Novel Alzheimer’s Disease Treatment to Traditional Approval
The U.S. Food and Drug Administration converted Leqembi (lecanemab-irmb), indicated to treat adult patients with Alzheimer’s Disease, to traditional approval following a determination that a confirmatory trial verified clinical benefit.
NIH Grants and Funding Opportunities Announced
The PHS 2023-2 omnibus solicitations of the NIH, CDC, and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant applications have been released. The first application due date is Tuesday, September 5, 2023.
Tonix Pharmaceuticals Enters into Agreement to Acquire Two FDA-Approved, Marketed Migraine Products from Upsher-Smith Laboratories, LLC
Zembrace® SymTouch® (sumatriptan injection) and Tosymra® (sumatriptan nasal spray) are indicated for the treatment of acute migraine in adults. Strategic acquisition helps build Tonix’s commercial capabilities and infrastructure ahead of potential launch of TNX-102 SL for the treatment of fibromyalgia.
Montana State researchers harness artificial intelligence for cancer diagnosis
While the linguistic feats of ChatGPT and other chatbots have been capturing headlines, researchers at Montana State University have been steadily advancing another, more ordinary — and potentially life-saving — application of artificial intelligence: helping to diagnose and treat prostate cancer.
CDC advisory panel backs use of GSK and Pfizer RSV vaccines in adults 60 and older
The panel’s decision moves the U.S. one step closer to making jabs against respiratory syncytial virus available to the public this fall, when the disease typically begins to spread at higher levels.
Microbion to Present New Data Demonstrating that Pravibismane Disrupts Bacterial Bioenergetics
Microbion Corporation has announced that the company has been selected to present a poster highlighting the results from an E. coli CRISPR/Cas gene expression knockdown study characterizing pravibismane’s mechanism of action at the ASM Microbe Conference to be held in Houston, TX from June 15-19th, 2023.
CSBI Releases the 2023 Life Sciences Workforce Trends Report at BIO International Convention
The biennial report provides a national snapshot of the most pressing current and anticipated talent needs of the nation’s dynamic life science industry. This year’s report distills a set of key themes sourced from 185 executive interviews and nearly 700 survey responses from companies in eighteen states and Puerto Rico, as well as an assessment of nearly 2.8M job postings from life science companies over the last four years.
MSU Extension and Montana Department of Agriculture join new USDA regional food business center partnership
Montana State University Extension and the Montana Department of Agriculture were recently announced as partners in a $30 million U.S. Department of Agriculture effort to establish a regional center to create opportunities for food producers and increase food security.
Tonix Pharmaceuticals Announces the Isolation and Characterization of the (S)-Isomer of Tianeptine
TNX-4300’s Mechanism of Restoring Neuroplasticity Supports Development as a First-in-Class Oral Therapy for Depression, Bipolar Disorder, Alzheimer’s Disease and Parkinson’s Disease